Top Page
CMOC Group
(3993)
CMOC Group (3993) vs. iShares MSCI Hong Kong ETF (EWH)
CMOC Group Business Overview & Revenue Model
CMOC Group Earnings Call Summary
CMOC Group Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.74B | 213.03B | 186.27B | 172.99B | 173.86B | 112.98B |
| Gross Profit | 39.94B | 35.25B | 17.83B | 16.06B | 16.32B | 8.45B |
| EBITDA | 36.74B | 31.39B | 20.17B | 17.10B | 17.11B | 9.01B |
| Net Income | 19.54B | 13.53B | 8.25B | 6.07B | 5.11B | 2.33B |
Balance Sheet | ||||||
| Total Assets | 184.19B | 170.24B | 172.97B | 165.02B | 137.45B | 122.44B |
| Cash, Cash Equivalents and Short-Term Investments | 40.26B | 36.94B | 39.00B | 36.88B | 31.44B | 24.38B |
| Total Debt | 30.50B | 29.64B | 50.86B | 48.66B | 46.86B | 47.03B |
| Total Liabilities | 90.46B | 84.29B | 101.01B | 102.98B | 89.19B | 75.11B |
| Stockholders Equity | 77.69B | 71.02B | 59.54B | 51.70B | 39.85B | 38.89B |
Cash Flow | ||||||
| Free Cash Flow | 26.05B | 27.49B | 2.62B | 4.94B | 1.91B | 870.66M |
| Operating Cash Flow | 31.15B | 32.39B | 15.54B | 15.45B | 6.19B | 8.49B |
| Investing Cash Flow | 4.57B | -1.16B | -10.66B | -7.37B | -4.89B | -9.40B |
| Financing Cash Flow | -32.98B | -30.57B | -8.61B | -2.10B | 7.89B | 422.30M |
CMOC Group Technical Analysis
CMOC Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$39.21B | 13.91 | 24.57% | 1.89% | 60.77% | 100.45% | |
70 Outperform | HK$565.27B | 22.56 | 27.23% | 1.45% | -2.42% | 38.68% | |
70 Outperform | HK$55.10B | 54.44 | 36.46% | 1.32% | 31.24% | 58.16% | |
67 Neutral | HK$4.01B | 10.81 | 4.82% | 6.84% | 160.79% | -28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | HK$98.73B | -37.03 | -4.63% | 2.80% | -39.59% | 69.00% | |
44 Neutral | HK$2.25B | -3.90 | -14.35% | ― | -31.35% | -71.37% |
CMOC Group Corporate Events
CMOC Group Limited has issued a positive profit alert for 2025, projecting net profit attributable to shareholders of RMB20.0 billion to RMB20.8 billion, a year-on-year increase of about 48% to 54%. Net profit after deducting non-recurring items is expected to reach RMB20.4 billion to RMB21.2 billion, up roughly 56% to 62% from 2024, driven by higher sales volumes and prices of its major products alongside effective cost control, signaling a strong improvement in operating performance and earnings power ahead of the company’s full 2025 annual results.
The most recent analyst rating on (HK:3993) stock is a Hold with a HK$24.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co, through its wholly-owned subsidiary Xizang Shmok, has invested RMB500 million in a limited partnership fund managed by Boyu Capital. This fund aims to achieve favorable capital returns by focusing on high-growth sectors such as technology, healthcare, and consumer products. The investment will be accounted for as financial assets at fair value through profit or loss, reflecting the company’s strategic move to leverage idle cash for potential growth opportunities in these sectors.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced the composition of its board of directors, detailing the roles and functions of each member. The board consists of executive, non-executive, and independent non-executive directors, with specific members assigned to four committees: Audit and Risk, Nomination and Governance, Remuneration, and Strategic and Sustainability. This announcement underscores the company’s commitment to structured governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited, a joint stock company incorporated in the People’s Republic of China, held its 2025 second extraordinary general meeting (EGM) on December 8, 2025. During the meeting, shareholders approved several key resolutions, including the appointment of an executive director and a non-executive director, the cancellation of the supervisory committee, and adjustments to board committees. These changes are expected to streamline the company’s governance structure and enhance decision-making processes, potentially impacting the company’s operational efficiency and strategic direction.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced its investment in a private equity fund named Boyu Xinzhi Xinchan (Ningbo) Equity Investment Limited Partnership. The fund, managed by Boyu Tianshu, focuses on high-growth sectors such as technology, healthcare, and consumer products. CMOC’s subsidiary, Xizang Shmok, will contribute RMB500 million as a limited partner. This investment is considered a connected transaction due to the involvement of CATL, a connected person to CMOC, and it complies with the reporting requirements under Chapter 14A of the Listing Rules. The fund aims to raise RMB8-10 billion and will operate as a closed-ended fund with an initial term of 12 years.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has released the Detailed Working Rules of its Nomination and Governance Committee, which were approved at a recent board meeting. This announcement outlines the committee’s structure, duties, and procedures, emphasizing the company’s commitment to robust governance practices. The release is expected to enhance transparency and operational efficiency, potentially strengthening CMOC’s industry position and stakeholder confidence.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co., Ltd (CMOC) has announced the detailed working rules for its Audit and Risk Committee, which were passed at the fifth meeting of the seventh session of the Board on November 17, 2025. The release outlines the committee’s composition, duties, powers, meeting procedures, and resolution processes, indicating a structured approach to governance and risk management. This announcement signifies CMOC’s commitment to enhancing its corporate governance framework, potentially impacting its operational transparency and stakeholder confidence.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co has announced the adoption of new operation rules for its Remuneration Committee, as approved at the recent board meeting. This update is likely to enhance governance and operational efficiency, potentially impacting the company’s strategic positioning and stakeholder relations positively.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced the nomination of Mr. Ma Fei as a candidate for the position of non-executive director, pending shareholder approval at the 2025 extraordinary general meeting. Mr. Ma brings extensive experience in consulting and human resources, having held senior roles at various companies. Additionally, the company plans to cancel its supervisory committee and amend its articles of association to enhance its internal control systems. These changes are aimed at streamlining governance and aligning with updated legal guidelines, potentially impacting the company’s operational efficiency and stakeholder engagement.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co, a prominent player in the mining industry, has announced the convening of its 2025 second extraordinary general meeting (EGM) to be held in Shanghai, China. The meeting aims to address key resolutions, including the election of new directors to the board and the proposed cancellation of the supervisory committee, which could significantly impact the company’s governance structure.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited, a joint stock company incorporated in China, has announced changes in its company secretary and authorized representative roles. Mr. Xu Hui has been confirmed as qualified to act as the sole company secretary following a waiver period, leading to the resignation of Ms. Ng Sau Mei from her joint secretary and authorized representative positions. The board expressed appreciation for Ms. Ng’s contributions, and Mr. Xu will assume her responsibilities, ensuring continuity in the company’s governance structure.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
China Molybdenum Co, a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their roles within various committees. The board comprises executive, non-executive, and independent non-executive directors, with specific members assigned to the Audit and Risk, Nomination and Governance, Remuneration, and Strategic and Sustainability Committees. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders to understand the decision-making framework and oversight within the organization.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$17.50 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced the resignation of its Executive Director and President, Mr. Sun Ruiwen, and Vice President and Chief Commercial Officer, Mr. Kenny Ives, citing personal work reasons and family commitments, respectively. The company assures that these changes will not affect its daily operations or board functionality. Additionally, Mr. Peng Xuhui has been proposed as a new Executive Director, bringing extensive experience in corporate management and strategic planning, which is expected to bolster the company’s leadership and operational strategies.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$17.50 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced its unaudited financial results for the third quarter ending September 30, 2025. The company reported a slight decrease in operating revenue by 2.36% compared to the same period last year, while total profit and net profit attributable to shareholders saw substantial increases of 64.37% and 96.40%, respectively. The financial report highlights a robust growth in profitability despite a decline in revenue, indicating improved operational efficiency and cost management. This performance may strengthen CMOC’s position in the mining industry and provide positive implications for its stakeholders.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$17.50 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
CMOC Group Limited has announced an online briefing session for its 2025 third quarterly results, scheduled for October 28, 2025. The session aims to facilitate interaction with investors, allowing them to appraise the company’s performance and operations. Independent non-executive directors and management will participate, providing an opportunity for stakeholders to engage and have their questions addressed.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$17.50 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.